These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17478464)

  • 1. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout.
    Willburger RE; Mysler E; Derbot J; Jung T; Thurston H; Kreiss A; Litschig S; Krammer G; Tate GA
    Rheumatology (Oxford); 2007 Jul; 46(7):1126-32. PubMed ID: 17478464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
    Rubin BR; Burton R; Navarra S; Antigua J; Londoño J; Pryhuber KG; Lund M; Chen E; Najarian DK; Petruschke RA; Ozturk ZE; Geba GP
    Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.
    Fleischmann R; Tannenbaum H; Patel NP; Notter M; Sallstig P; Reginster JY
    BMC Musculoskelet Disord; 2008 Mar; 9():32. PubMed ID: 18328090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials.
    Daniels S; Gitton X; Zhou W; Stricker K; Barton S
    J Womens Health (Larchmt); 2008 Apr; 17(3):423-37. PubMed ID: 18373490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain.
    Kyle C; Zachariah J; Kinch H; Ellis G; Andrews C; Adekunle F
    Int J Clin Pract; 2008 Nov; 62(11):1684-92. PubMed ID: 19143855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis.
    Schnitzer TJ; Dattani ID; Seriolo B; Schneider H; Moore A; Tseng L; Sallstig P; Rebuli R; Maxwell T
    Clin Rheumatol; 2011 Nov; 30(11):1433-46. PubMed ID: 21607551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumiracoxib is effective in the treatment of episodic tension-type headache.
    Packman E; Packman B; Thurston H; Tseng L
    Headache; 2005 Oct; 45(9):1163-70. PubMed ID: 16178946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee.
    Sheldon EA; Beaulieu A; Paster Z; Yu S; Rebuli R
    Clin Exp Rheumatol; 2008; 26(4):611-9. PubMed ID: 18799092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial.
    MacDonald TM; Reginster JY; Littlejohn TW; Richard D; Lheritier K; Krammer G; Rebuli R
    J Hypertens; 2008 Aug; 26(8):1695-702. PubMed ID: 18622250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial.
    Fricke J; Davis N; Yu V; Krammer G
    J Pain; 2008 Jan; 9(1):20-7. PubMed ID: 17933588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
    Navarra S; Rubin BR; Yu Q; Smugar SS; Tershakovec AM
    Curr Med Res Opin; 2007 Jul; 23(7):1685-91. PubMed ID: 17588299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain.
    Schattenkirchner M; Milachowski KA
    Clin Rheumatol; 2003 May; 22(2):127-35. PubMed ID: 12740678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Schnitzer TJ; Beier J; Geusens P; Hasler P; Patel SK; Senftleber I; Gitton X; Moore A; Sloan VS; Poór G
    Arthritis Rheum; 2004 Aug; 51(4):549-57. PubMed ID: 15334426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis.
    Dougados M; Moore A; Yu S; Gitton X
    Arthritis Res Ther; 2007; 9(1):R11. PubMed ID: 17266764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand.
    Grifka JK; Zacher J; Brown JP; Seriolo B; Lee A; Moore A; Gimona A
    Clin Exp Rheumatol; 2004; 22(5):589-96. PubMed ID: 15485012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.
    Taylor TH; Mecchella JN; Larson RJ; Kerin KD; Mackenzie TA
    Am J Med; 2012 Nov; 125(11):1126-1134.e7. PubMed ID: 23098865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
    Batlle-Gualda E; Figueroa M; Ivorra J; Raber A
    J Rheumatol; 1996 Jul; 23(7):1200-6. PubMed ID: 8823693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial.
    Li T; Chen SL; Dai Q; Han XH; Li ZG; Wu DH; Zhang X; Gu JR; Yang NP; Sun LY; Zhang MJ; Li XF; Bao CD
    Chin Med J (Engl); 2013; 126(10):1867-71. PubMed ID: 23673101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.